\-\ Texto\\:\\ \ \(0\)\
\-\ musculoskeletal\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ adequately\\ aligned\\ spine\\.\\ diffuse\\ joint\\ tenderness\\;\\ no\\ joint\\ erythema\\.\\ normal\\ muscular\\ development\\.\\ normal\\ gait\\.\ \(0\)\
\-\ \\â\\€\\¢\\ range\\ of\\ motion\\:\ \(0\)\
\-\ \\Â\\»\\ limited\\ cervical\\ extension\\ \\(67\\%\\ of\\ normal\\)\\,\\ r\\ and\\ l\\ lateral\\ cervical\\ bending\\ \\(45\\%\\ and\\ 64\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ cervical\\ flexion\\,\\ extension\\,\\ rotation\\ elicits\\ pain\\ in\\ the\\ back\\ of\\ the\\ neck\\ that\\ radiates\\ to\\ shoulder\\.\ \(0\)\
\-\ \\Â\\»\\ limited\\ lumbar\\ flexion\\ \\(85\\%\\ of\\ normal\\)\\ and\\ extension\\ \\(60\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ limited\\ lumbar\\ r\\ and\\ l\\ lateral\\ bending\\ \\(68\\%\\ and\\ 84\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ lumbar\\ flexion\\ elicits\\ pain\\ in\\ low\\ back\\,\\ both\\ buttocks\\ and\\ thighs\\ down\\ to\\ knees\\.\ \(0\)\
\-\ \\Â\\»\\ lumbar\\ extension\\ elicits\\ pain\\ in\\ low\\ back\\;\\ denies\\ radiation\\.\ \(0\)\
\-\ \\Â\\»\\ normal\\ rom\\ in\\ r\\ and\\ l\\ straight\\ leg\\ raise\\.\ \(0\)\
\-\ \\Â\\»\\ r\\ leg\\ raise\\ elicits\\ pain\\ in\\ low\\ back\\,\\ r\\ buttock\\,\\ and\\ r\\ thigh\\.\ \(0\)\
\-\ \\Â\\»\\ l\\ leg\\ raise\\ elicits\\ pain\\ in\\ low\\ back\\,\\ l\\ buttock\\,\\ and\\ l\\ thigh\\.\ \(0\)\
\-\ \\â\\€\\¢\\ algometer\\ study\\,\\ as\\ done\\ per\\ protocol\\,\\ elicited\\ increased\\ sensitivity\\ to\\ pain\\ bilaterally\\ at\\:\\ suboccipital\\ muscle\\ insertions\\;\\ midpoint\\ of\\ upper\\ border\\ of\\ trapezius\\ muscle\\;\\ supraspinatus\\ muscle\\ above\\ the\\ scapula\\ spines\\;\\ second\\ costochondral\\ junctions\\;\\ 2\\ centimeters\\ distal\\ to\\ lateral\\ epicondyles\\ of\\ the\\ elbows\\;\\ upper\\ outer\\ quadrants\\ of\\ buttocks\\;\\ piriformis\\ insertion\\;\\ medial\\ aspect\\ of\\ knees\\.\\ no\\ increased\\ pain\\ sensitivity\\ at\\ the\\ anterior\\ aspects\\ of\\ inter\\-transverse\\ spaces\\ between\\ c5\\ and\\ c7\\.\ \(0\)\
\-\ neurological\\:\ \(0\)\
\-\ \\â\\€\\¢\\ monofilament\\ sensory\\ testing\\:\\ \ \(0\)\
\-\ \\Â\\»\\ diminished\\ light\\ touch\\ in\\ dorsal\\ surface\\ of\\ distal\\ r\\ forearm\\.\ \(0\)\
\-\ \\Â\\»\\ diminished\\ light\\ touch\\ in\\ plantar\\ surface\\ of\\ l\\ 5th\\ toe\\ and\\ distal\\ lateral\\ plantar\\ surface\\ of\\ l\\ foot\\.\ \(0\)\
\-\ \\â\\€\\¢\\ straight\\ leg\\ test\\:\\ positive\\ for\\ both\\ legs\\.\ \(0\)\
\-\ \\â\\€\\¢\\ motor\\:\\ \ \(0\)\
\-\ \\Â\\»\\ shoulder\\ abduction\\-\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ elbow\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 26\\.1\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ elbow\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ hip\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 19\\.7\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ hip\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 26\\.7\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ hallux\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ hallux\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\â\\€\\¢\\ jamar\\ grip\\ dynamometer\\:\\ r\\ 60lbs\\;\\ l\\ 55lbs\\;\\ r\\-handed\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cranial\\ nerves\\:\\ ii\\-xii\\ intact\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ deep\\ tendon\\ reflexes\\:\\ \\+2\\ at\\ brachioradialis\\,\\ biceps\\,\\ triceps\\,\\ patellar\\,\\ and\\ achilles\\ bilaterally\\.\ \(0\)\
\-\ \\â\\€\\¢\\ skin\\:\\ diffuse\\ abnormal\\ pigmentation\\,\\ especially\\ on\\ the\\ upper\\ extremities\\,\\ chest\\,\\ upper\\ back\\,\\ abdomen\\.\\ no\\ lesions\\ or\\ eruptions\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ cocchiarella\\ l\\,\\ andersson\\ gbj\\.\\ guidelines\\ to\\ the\\ evaluation\\ of\\ permanent\\ impairment\\ \\(5e\\)\\.\\ chicago\\:\\ ama\\ press\\;\\ 2001\\.\ \(0\)\
\-\ the\\ patient\\ continues\\ to\\ receive\\ thorough\\ chiropractic\\ care\\ to\\ the\\ cervical\\ and\\ lumbar\\ spine\\,\\ and\\ upper\\ and\\ lower\\ extremities\\ for\\ symptomatic\\ relief\\ of\\ his\\ arthralgia\\.\\ the\\ patient\\ was\\ instructed\\ to\\ take\\ over\\-the\\-counter\\ doses\\ of\\ acetaminophen\\ as\\ needed\\ to\\ alleviate\\ diffuse\\ pain\\,\\ as\\ well\\ as\\ lifestyle\\ modifications\\ involving\\ improved\\ diet\\ and\\ exercise\\.\\ \\ further\\ evaluation\\ is\\ needed\\,\\ with\\ possible\\ administration\\ of\\ tri\\-cyclic\\ antidepressants\\ \\(amitriptyline\\ or\\ cyclobenzaprine\\)\\,\\ serotonin\\-norepinephrine\\ reuptake\\ inhibitors\\ \\(duloxetine\\ or\\ milnacipran\\)\\,\\ or\\ gabapentinoids\\ \\(pregabalin\\,\\ gabapentin\\)\\ \\ if\\ a\\ diagnosis\\ of\\ fibromyalgia\\ is\\ confirmed\\ \\[1\\]\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ schmidt\\-wilcke\\ t\\,\\ clauw\\ dj\\.\\ fibromyalgia\\:\\ from\\ pathophysiology\\ to\\ therapy\\.\\ nat\\ rev\\ rheumatol\\.\\ 2011\\;7\\(9\\)\\:518\\.\ \(0\)\
\-\ unenhanced\\ multiplanar\\ 3\\-t\\ mri\\ imaging\\ of\\ the\\ lumbar\\ spine\\ from\\ t11\\-12\\ to\\ l5\\-s1\\:\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ conus\\ terminates\\ at\\ the\\ level\\ of\\ the\\ t12\\-l1\\ disc\\ space\\,\\ and\\ within\\ limits\\ of\\ the\\ study\\.\\ no\\ distal\\ cord\\ abnormality\\ is\\ seen\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ t11\\-12\\,\\ t12\\-l1\\,\\ l1\\-l2\\,\\ l2\\-l3\\,\\ and\\ l3\\-l4\\,\\ the\\ canal\\ and\\ the\\ neural\\ foramina\\ are\\ patent\\.\\ there\\ is\\ no\\ annular\\ bulge\\.\\ the\\ discs\\ are\\ well\\ hydrated\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ l4\\-5\\,\\ there\\ is\\ a\\ shallow\\ annular\\ bulge\\ and\\ mild\\ facet\\ arthropathy\\.\\ overall\\,\\ the\\ canal\\ and\\ the\\ neural\\ foramina\\ still\\ maintain\\ their\\ caliber\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ l5\\-s1\\,\\ the\\ canal\\ tapers\\ in\\ diameter\\ due\\ to\\ increased\\ deposition\\ of\\ epidural\\ fat\\.\\ the\\ disc\\ remains\\ well\\ hydrated\\ and\\ the\\ neural\\ foramina\\ are\\ patent\\.\ \(0\)\
\-\ patient\\ photos\\:\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ macules\\ and\\ patches\\ chest\\,\\ abdomen\\,\\ and\\ thighs\\ with\\ sloughing\\ and\\ epidermal\\ loss\\ \\â\\€\\“\\ characteristic\\ of\\ stevens\\-johnson\\ syndrome\\.\ \(0\)\
\-\ post\\ stevens\\-johnson\\ syndrome\\,\\ resembling\\ fibromyalgia\ \(0\)\
\-\ \\â\\€\\¢\\ fibromyalgia\ \(0\)\
\-\ \\â\\€\\¢\\ recurrent\\ arthralgia\\ secondary\\ to\\ stevens\\-johnson\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ myofascial\\ pain\\ syndrome\\ \\(mps\\)\ \(0\)\
\-\ \\â\\€\\¢\\ chronic\\ fatigue\\ syndrome\\ \\(cfs\\)\ \(0\)\
\-\ \\â\\€\\¢\\ cervical\\ and\\ lumbar\\ disc\\ herniations\ \(0\)\
\-\ this\\ is\\ a\\ 22\\ woman\\ who\\ was\\ referred\\ for\\ further\\ diagnosis\\ of\\ her\\ worsening\\ pain\\ in\\ her\\ neck\\ and\\ low\\ back\\.\\ she\\ first\\ noticed\\ the\\ pain\\ after\\ recovering\\ from\\ stevens\\-johnson\\ syndrome\\ in\\ about\\ 14\\ months\\ ago\\,\\ following\\ the\\ use\\ of\\ bactrim\\ for\\ mastitis\\.\\ she\\ states\\ that\\ her\\ neck\\ and\\ low\\ back\\ pain\\ is\\ constant\\,\\ and\\ is\\ described\\ it\\ as\\ a\\ nagging\\ ache\\ with\\ a\\ deep\\ stabbing\\ sensation\\ when\\ aggravated\\.\\ \\ her\\ neck\\ pain\\ is\\ aggravated\\ by\\ movement\\ and\\ physical\\ activity\\ \\(e\\.g\\.\\ cradling\\ her\\ baby\\)\\,\\ and\\ radiates\\ to\\ her\\ shoulders\\.\\ her\\ low\\ back\\ pain\\ is\\ also\\ aggravated\\ by\\ movement\\ and\\ physical\\ activity\\,\\ and\\ radiates\\ to\\ her\\ buttocks\\ and\\ thighs\\ bilaterally\\.\\ she\\ also\\ states\\ that\\ her\\ arms\\ and\\ legs\\ feel\\ weaker\\,\\ especially\\ on\\ the\\ left\\ side\\.\\ she\\ denies\\ any\\ associated\\ fevers\\,\\ headaches\\,\\ or\\ loss\\ of\\ function\\ of\\ any\\ muscles\\/extremities\\.\\ she\\ has\\ tried\\ using\\ nsaids\\,\\ specifically\\ aspirin\\ and\\ ibuprofen\\,\\ but\\ they\\ have\\ provided\\ little\\ relief\\.\\ patient\\ rates\\ her\\ current\\ discomfort\\ at\\ a\\ 5\\/10\\,\\ but\\ rates\\ her\\ maximum\\ pain\\ when\\ aggravated\\ at\\ an\\ 8\\/10\\.\\ she\\ does\\ not\\ recall\\ ever\\ having\\ a\\ similar\\ episode\\ of\\ neck\\ and\\ low\\ back\\ pain\\ in\\ the\\ past\\.\ \(0\)\
\-\ her\\ past\\ medical\\ history\\ is\\ significant\\ for\\ stevens\\-johnson\\ syndrome\\ with\\ dermatological\\ and\\ ophthalmic\\ sequelae\\.\\ \\ patient\\ is\\ not\\ on\\ any\\ medications\\,\\ is\\ allergic\\ to\\ bactrim\\,\\ and\\ denies\\ alcohol\\,\\ tobacco\\,\\ or\\ illicit\\/iv\\ drug\\ use\\.\ \(0\)\
\-\ case\\ contributors\\:michael\\ r\\ carag\\,\\ msiii\\,\\ joanna\\ garvey\\,\\ dc\\;\\ geoffrey\\ gerow\\,\\ dc\\;\\ randall\\ loftus\\,\\ md\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\ md\\,\\ vaseem\\ iqbqal\\ md\\.\\ \ \(0\)\
\-\ fibromyalgia\\ is\\ a\\ chronic\\ condition\\ characterized\\ by\\ widespread\\ pain\\ and\\ increased\\ sensitivity\\ to\\ pressure\\ \\[1\\]\\.\\ prominent\\ concomitant\\ symptoms\\ include\\ chronic\\ fatigue\\,\\ cold\\ extremities\\,\\ cognitive\\ dysfunction\\,\\ sleep\\ disturbances\\,\\ anxiety\\ and\\/or\\ depression\\,\\ gait\\ instability\\,\\ and\\ muscle\\ twitching\\ \\[2\\]\\.\\ diagnosis\\ is\\ made\\ according\\ to\\ the\\ american\\ college\\ of\\ rheumatology\\ guidelines\\,\\ which\\ requires\\ that\\ three\\ conditions\\ are\\ met\\ \\[3\\]\\:\\ \ \(0\)\
\-\ 1\\.\\ a\\ widespread\\ pain\\ index\\ \\(wpi\\)\\ \\>\\ 7\\ and\\ symptom\\ severity\\ \\(ss\\)\\ scale\\ score\\ \\>\\ 5\\ or\\ wpi\\ 3\\-6\\ and\\ ss\\ \\>\\ 9\\.\ \(0\)\
\-\ 2\\.\\ persistent\\ symptoms\\ for\\ at\\ least\\ 3\\ months\\.\\ \ \(0\)\
\-\ 3\\.\\ no\\ other\\ disorder\\ that\\ would\\ otherwise\\ explain\\ the\\ pain\\.\ \(0\)\
\-\ wpi\\ is\\ scored\\ on\\ a\\ 0\\-19\\ scale\\,\\ with\\ one\\ point\\ assigned\\ if\\ the\\ patient\\ has\\ experienced\\ pain\\ over\\ the\\ last\\ week\\ in\\ various\\ locations\\:\\ r\\/l\\ shoulder\\ girdle\\;\\ r\\/l\\ upper\\ arm\\;\\ r\\/l\\ lower\\ arm\\;\\ r\\/l\\ hip\\;\\ r\\/l\\ upper\\ leg\\;\\ r\\/l\\ lower\\ leg\\;\\ r\\/l\\ jaw\\;\\ chest\\;\\ abdomen\\;\\ upper\\ back\\;\\ lower\\ back\\;\\ and\\ neck\\.\\ symptom\\ severity\\ score\\ asks\\ the\\ patient\\ to\\ rate\\ level\\ of\\ fatigue\\,\\ waking\\ unfreshed\\,\\ and\\ cognitive\\ symptoms\\ each\\ from\\ 0\\ \\(no\\ problem\\)\\ to\\ 3\\ \\(severe\\ problem\\)\\.\\ \\ \ \(0\)\
\-\ the\\ cause\\ of\\ fibromyalgia\\ is\\ unknown\\,\\ however\\ studies\\ postulate\\ that\\ a\\ stressor\\ triggering\\ abnormal\\ central\\ nervous\\ system\\ pain\\ processing\\ \\â\\€\\“\\ central\\ sensitization\\ \\â\\€\\“\\ is\\ to\\ blame\\ \\[4\\]\\.\\ psychological\\ stressors\\ \\â\\€\\“\\ death\\ of\\ a\\ loved\\ one\\,\\ prolonged\\ hospitalization\\,\\ trauma\\ or\\ mva\\[5\\]\\ \\ \\â\\€\\“\\ and\\ biological\\ stressors\\ \\â\\€\\“\\ infections\\ \\(lyme\\ disease\\,\\ ebv\\,\\ parvovirus\\,\\ q\\ fever\\)\\,\\ acute\\ gi\\ \\ infections\\ \\(campylobacter\\,\\ salmonella\\,\\ shigella\\)\\,\\ status\\-post\\ surgery\\ or\\ prolonged\\ illness\\ \\â\\€\\“\\ are\\ all\\ associated\\ with\\ an\\ increased\\ risk\\ of\\ developing\\ fibromyalgia\\ \\[1\\]\\.\\ further\\ studies\\ have\\ also\\ noted\\ an\\ aggregation\\ of\\ fibromyalgia\\ in\\ patient\\ families\\ and\\ specific\\ polymorphisms\\ in\\ serotoninergic\\,\\ dopaminergic\\,\\ and\\ catecholaminergic\\ systems\\,\\ suggesting\\ a\\ polygenic\\ mode\\ of\\ inheritance\\ \\[6\\]\\.\ \(0\)\
\-\ with\\ regards\\ to\\ our\\ lg\\,\\ wpi\\ was\\ scored\\ at\\ 18\\ out\\ of\\ 19\\,\\ with\\ pain\\ experienced\\ everywhere\\ but\\ the\\ jaw\\.\\ ss\\ scale\\ score\\ was\\ also\\ greater\\ than\\ 5\\,\\ with\\ lg\\ complaining\\ of\\ all\\ three\\ symptoms\\.\\ furthermore\\,\\ in\\ relation\\ to\\ the\\ 1990\\ american\\ college\\ of\\ rheumatology\\ guidelines\\ for\\ fibromyalgia\\ diagnosis\\,\\ pain\\ upon\\ palpation\\ was\\ elicited\\ at\\ 17\\ out\\ of\\ the\\ 18\\ tenderness\\ points\\,\\ excluding\\ the\\ anterior\\ aspects\\ of\\ inter\\-transverse\\ spaces\\ between\\ c5\\ and\\ c7\\ \\[2\\]\\.\\ given\\ these\\ findings\\ through\\ the\\ history\\ of\\ present\\ illness\\,\\ review\\ of\\ symptoms\\,\\ and\\ physical\\ exam\\,\\ paired\\ with\\ a\\ negative\\ mri\\ of\\ the\\ lumbar\\ spine\\,\\ we\\ concluded\\ that\\ the\\ condition\\ affecting\\ lg\\ most\\ closely\\ correlated\\ with\\ fibromyalgia\\,\\ likely\\ secondary\\ to\\ her\\ recent\\ episode\\ of\\ stevens\\-johnson\\ syndrome\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ schmidt\\-wilcke\\ t\\,\\ clauw\\ dj\\.\\ fibromyalgia\\:\\ from\\ pathophysiology\\ to\\ therapy\\.\\ nat\\ rev\\ rheumatol\\.\\ 2011\\;7\\(9\\)\\:518\\.\ \(0\)\
\-\ 2\\.\\ chaitow\\ l\\,\\ et\\ al\\.\\ fibromyalgia\\ syndrome\\:\\ a\\ practitioner\\â\\€\\™s\\ guide\\ to\\ treatment\\.\\ new\\ york\\:\\ churchill\\ livingston\\;\\ 2000\\.\ \(0\)\
\-\ 3\\.\\ wolfe\\ f\\,\\ et\\ al\\.\\ the\\ american\\ college\\ of\\ rheumatology\\ preliminary\\ diagnostic\\ criteria\\ for\\ fibromyalgia\\ and\\ measurement\\ of\\ symptom\\ severity\\.\\ arthritis\\ care\\ res\\ \\(hoboken\\)\\.\\ 2010\\ may\\;62\\(5\\)\\:600\\-10\\.\ \(0\)\
\-\ 4\\.\\ bernstein\\ cd\\,\\ weiner\\ dk\\.\\ chapter\\ 123\\.\\ fibromyalgia\\ and\\ myofascial\\ pain\\ syndromes\\.\\ in\\:\\ halter\\ jb\\,\\ ouslander\\ jg\\,\\ tinetti\\ me\\,\\ studenski\\ s\\,\\ high\\ kp\\,\\ asthana\\ s\\,\\ eds\\.\\ hazzard\\'s\\ geriatric\\ medicine\\ and\\ gerontology\\.\\ 6th\\ ed\\.\\ new\\ york\\:\\ mcgraw\\-hill\\;\\ 2009\\.\\ http\\:\\/\\/www\\.accessmedicine\\.com\\/content\\.aspx\\?aid\\=5136432\\.\\ accessed\\ march\\ 7\\,\\ 2013\\.\ \(0\)\
\-\ 5\\.\\ papageorgiou\\,\\ a\\.\\ c\\.\\,\\ silman\\,\\ a\\.\\ j\\.\\ \\&\\ macfarlane\\,\\ g\\.\\ j\\.\\ chronic\\ widespread\\ pain\\ in\\ the\\ population\\:\\ a\\ seven\\ year\\ follow\\ up\\ study\\.\\ ann\\.\\ rheum\\.\\ dis\\.\\ 61\\,\\ 1071\\-1074\\ \\(2002\\)\\.\ \(0\)\
\-\ 6\\.\\ buskila\\ d\\,\\ sarzi\\-puttini\\ p\\.\\ biology\\ and\\ therapy\\ of\\ fibromyalgia\\.\\ genetic\\ aspects\\ of\\ fibromyalgia\\ syndrome\\.\\ arthritis\\ res\\ ther\\.\\ 2006\\;8\\(5\\)\\:218\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fibromyalgia\\:\\ 0\\.39661965392636805\ \(0\)\
\-\ and\\:\\ 0\\.2042078964912549\ \(0\)\
\-\ of\\:\\ 0\\.17932933673016385\ \(0\)\
\-\ the\\:\\ 0\\.16492244606413467\ \(0\)\
\-\ pain\\:\\ 0\\.16074044816040645\ \(0\)\
\-\ her\\:\\ 0\\.14593017514022064\ \(0\)\
\-\ back\\:\\ 0\\.14380047582202748\ \(0\)\
\-\ elicits\\:\\ 0\\.1372880420507294\ \(0\)\
\-\ to\\:\\ 0\\.11679119642263243\ \(0\)\
\-\ lumbar\\:\\ 0\\.11607104636978585\ \(0\)\
\-\ wpi\\:\\ 0\\.11493908685186187\ \(0\)\
\-\ on\\:\\ 0\\.11395964404656954\ \(0\)\
\-\ syndrome\\:\\ 0\\.10832221376731721\ \(0\)\
\-\ flexion\\:\\ 0\\.09158291803186351\ \(0\)\
\-\ aggravated\\:\\ 0\\.08955233820082438\ \(0\)\
\-\ extension\\:\\ 0\\.08903460949678632\ \(0\)\
\-\ is\\:\\ 0\\.08857194626156058\ \(0\)\
\-\ low\\:\\ 0\\.08248116605336846\ \(0\)\
\-\ md\\:\\ 0\\.08190528317363512\ \(0\)\
\-\ at\\:\\ 0\\.08144097237801992\ \(0\)\
\-\ leg\\:\\ 0\\.08138536333243714\ \(0\)\
\-\ in\\:\\ 0\\.08045747335088523\ \(0\)\
\-\ lg\\:\\ 0\\.07965433987768697\ \(0\)\
\-\ upper\\:\\ 0\\.07681464247343364\ \(0\)\
\-\ ss\\:\\ 0\\.0685165017906849\ \(0\)\
\-\ thighs\\:\\ 0\\.0678162098499846\ \(0\)\
\-\ rheumatology\\:\\ 0\\.0678162098499846\ \(0\)\
\-\ college\\:\\ 0\\.06716425365061829\ \(0\)\
\-\ neck\\:\\ 0\\.0659492037732271\ \(0\)\
\-\ guidelines\\:\\ 0\\.06544138479956002\ \(0\)\
\-\ cervical\\:\\ 0\\.06434507178142534\ \(0\)\
\-\ she\\:\\ 0\\.06417559659191169\ \(0\)\
\-\ buttocks\\:\\ 0\\.06398471994152582\ \(0\)\
\-\ widespread\\:\\ 0\\.0631250714953843\ \(0\)\
\-\ or\\:\\ 0\\.06250753360650023\ \(0\)\
\-\ score\\:\\ 0\\.06126623458877517\ \(0\)\
\-\ radiates\\:\\ 0\\.05943153464759391\ \(0\)\
\-\ normal\\:\\ 0\\.05868976868487602\ \(0\)\
\-\ foramina\\:\\ 0\\.05813503662101671\ \(0\)\
\-\ clauw\\:\\ 0\\.057469543425930934\ \(0\)\
\-\ stressors\\:\\ 0\\.057469543425930934\ \(0\)\
\-\ aspects\\:\\ 0\\.05578717197925771\ \(0\)\
\-\ raise\\:\\ 0\\.05523655312454144\ \(0\)\
\-\ symptom\\:\\ 0\\.05488652730036652\ \(0\)\
\-\ sensitivity\\:\\ 0\\.05471625932756575\ \(0\)\
\-\ extremities\\:\\ 0\\.05461913680770747\ \(0\)\
\-\ that\\:\\ 0\\.05458212051972397\ \(0\)\
\-\ scale\\:\\ 0\\.05375445186668738\ \(0\)\
\-\ severity\\:\\ 0\\.05316365844930824\ \(0\)\
\-\ arthralgia\\:\\ 0\\.053102893251791315\ \(0\)\
\-\ nat\\:\\ 0\\.053102893251791315\ \(0\)\
\-\ myofascial\\:\\ 0\\.053102893251791315\ \(0\)\
\-\ fatigue\\:\\ 0\\.05221109266821518\ \(0\)\
\-\ rheumatol\\:\\ 0\\.05169714588019099\ \(0\)\
\-\ bactrim\\:\\ 0\\.05169714588019099\ \(0\)\
\-\ muscle\\:\\ 0\\.05103392472356632\ \(0\)\
\-\ deficit\\:\\ 0\\.050997939835548886\ \(0\)\
\-\ dj\\:\\ 0\\.05054856664615214\ \(0\)\
\-\ neural\\:\\ 0\\.04992296195822861\ \(0\)\
\-\ scored\\:\\ 0\\.04957745674079601\ \(0\)\
\-\ symptoms\\:\\ 0\\.049155406867588\ \(0\)\
\-\ left\\:\\ 0\\.049034261353609276\ \(0\)\
\-\ hydrated\\:\\ 0\\.04873624307765171\ \(0\)\
\-\ increased\\:\\ 0\\.04858124748830297\ \(0\)\
\-\ rev\\:\\ 0\\.047994240040512955\ \(0\)\
\-\ spine\\:\\ 0\\.047478587328121685\ \(0\)\
\-\ disc\\:\\ 0\\.046830925326366284\ \(0\)\
\-\ patient\\:\\ 0\\.04675275275575741\ \(0\)\
\-\ hallux\\:\\ 0\\.04673006592012391\ \(0\)\
\-\ res\\:\\ 0\\.04673006592012391\ \(0\)\
\-\ american\\:\\ 0\\.04599040566575945\ \(0\)\
\-\ diffuse\\:\\ 0\\.04507268406562804\ \(0\)\
\-\ surface\\:\\ 0\\.04497470495496072\ \(0\)\
\-\ for\\:\\ 0\\.043567745767563865\ \(0\)\
\-\ denies\\:\\ 0\\.04347514571175602\ \(0\)\
\-\ limited\\:\\ 0\\.043023884634204514\ \(0\)\
\-\ references\\:\\ 0\\.04297504929643235\ \(0\)\
\-\ 19\\:\\ 0\\.04268722145683887\ \(0\)\
\-\ chronic\\:\\ 0\\.04266120670087815\ \(0\)\
\-\ buttock\\:\\ 0\\.04208338099692286\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.04208338099692286\ \(0\)\
\-\ shoulder\\:\\ 0\\.04187287524830214\ \(0\)\
\-\ distal\\:\\ 0\\.04175945884035498\ \(0\)\
\-\ right\\:\\ 0\\.04169998881958602\ \(0\)\
\-\ cognitive\\:\\ 0\\.04155809816031142\ \(0\)\
\-\ canal\\:\\ 0\\.04149059142769431\ \(0\)\
\-\ hip\\:\\ 0\\.041407699520491656\ \(0\)\
\-\ york\\:\\ 0\\.04107326326073416\ \(0\)\
\-\ no\\:\\ 0\\.040900963981073415\ \(0\)\
\-\ elicited\\:\\ 0\\.040202951418597865\ \(0\)\
\-\ jaw\\:\\ 0\\.039621023098395936\ \(0\)\
\-\ annular\\:\\ 0\\.039088333153874694\ \(0\)\
\-\ 2011\\:\\ 0\\.03875669108067781\ \(0\)\
\-\ with\\:\\ 0\\.03870198716916493\ \(0\)\
\-\ knees\\:\\ 0\\.03744861612373329\ \(0\)\
\-\ rates\\:\\ 0\\.03744861612373329\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03725797178168433\ \(0\)\
\-\ lower\\:\\ 0\\.03672670639537748\ \(0\)\
\-\ plantar\\:\\ 0\\.03670661308659455\ \(0\)\
\-\ bending\\:\\ 0\\.03614874930417347\ \(0\)\
\-\ illness\\:\\ 0\\.03614874930417347\ \(0\)\
\-\ as\\:\\ 0\\.036091951710111606\ \(0\)\
\-\ study\\:\\ 0\\.03595011895550687\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03595011895550687\ \(0\)\
\-\ bulge\\:\\ 0\\.03593873837222526\ \(0\)\
\-\ from\\:\\ 0\\.035680674032322356\ \(0\)\
\-\ lateral\\:\\ 0\\.03566853003687151\ \(0\)\
\-\ diminished\\:\\ 0\\.03563629255523286\ \(0\)\
\-\ c7\\:\\ 0\\.0354424389662055\ \(0\)\
\-\ problem\\:\\ 0\\.0354424389662055\ \(0\)\
\-\ thigh\\:\\ 0\\.035347704180211686\ \(0\)\
\-\ legs\\:\\ 0\\.035347704180211686\ \(0\)\
\-\ touch\\:\\ 0\\.03525437292425632\ \(0\)\
\-\ further\\:\\ 0\\.03510861377924736\ \(0\)\
\-\ c5\\:\\ 0\\.03498239926977084\ \(0\)\
\-\ any\\:\\ 0\\.03483711439979875\ \(0\)\
\-\ prolonged\\:\\ 0\\.03480739511214346\ \(0\)\
\-\ straight\\:\\ 0\\.03472168297973508\ \(0\)\
\-\ dc\\:\\ 0\\.03472168297973508\ \(0\)\
\-\ experienced\\:\\ 0\\.03415228648095537\ \(0\)\
\-\ are\\:\\ 0\\.0340902274002509\ \(0\)\
\-\ elbow\\:\\ 0\\.03392317961273798\ \(0\)\
\-\ also\\:\\ 0\\.03380656202042463\ \(0\)\
\-\ relief\\:\\ 0\\.03370211326195101\ \(0\)\
\-\ movement\\:\\ 0\\.033081965949593686\ \(0\)\
\-\ abdomen\\:\\ 0\\.03289045514334061\ \(0\)\
\-\ episode\\:\\ 0\\.03288811236056631\ \(0\)\
\-\ spaces\\:\\ 0\\.03270004631861714\ \(0\)\
\-\ patent\\:\\ 0\\.03257771733803776\ \(0\)\
\-\ infections\\:\\ 0\\.03172893641326101\ \(0\)\
\-\ states\\:\\ 0\\.03157208819808564\ \(0\)\
\-\ was\\:\\ 0\\.03131016004130599\ \(0\)\
\-\ gait\\:\\ 0\\.03112369582560947\ \(0\)\
\-\ light\\:\\ 0\\.03112369582560947\ \(0\)\
\-\ therapy\\:\\ 0\\.030971374302241422\ \(0\)\
\-\ needed\\:\\ 0\\.029670041420465552\ \(0\)\
\-\ physical\\:\\ 0\\.029228014766983695\ \(0\)\
\-\ arthritis\\:\\ 0\\.029227772524394676\ \(0\)\
\-\ algometer\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ epicondyles\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ 60lbs\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ 55lbs\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ cocchiarella\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ andersson\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ gbj\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ 5e\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ antidepressants\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ duloxetine\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ milnacipran\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ gabapentinoids\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ cradling\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ carag\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ unfreshed\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ postulate\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ stressor\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ blame\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ loved\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ serotoninergic\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ catecholaminergic\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ chaitow\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ wolfe\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ hoboken\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ weiner\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ ouslander\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ tinetti\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ studenski\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ asthana\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ hazzard\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ gerontology\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ papageorgiou\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ silman\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ macfarlane\\:\\ 0\\.028734771712965467\ \(0\)\
\-\ condition\\:\\ 0\\.028715315775454064\ \(0\)\
\-\ arm\\:\\ 0\\.028682589756136342\ \(0\)\
\-\ al\\:\\ 0\\.028553359695340202\ \(0\)\
\-\ chest\\:\\ 0\\.028453290528085044\ \(0\)\
\-\ especially\\:\\ 0\\.028426727400432887\ \(0\)\
\-\ et\\:\\ 0\\.028150782066998038\ \(0\)\
\-\ deep\\:\\ 0\\.02797331273831532\ \(0\)\
\-\ use\\:\\ 0\\.02749604380204959\ \(0\)\
\-\ piriformis\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ eruptions\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ reuptake\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ pregabalin\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ mps\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ dermatological\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ asks\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ sensitization\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ parvovirus\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ dopaminergic\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ polygenic\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ practitioner\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ livingston\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ dk\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ halter\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ kp\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ buskila\\:\\ 0\\.027457608410145877\ \(0\)\
\-\ 18\\:\\ 0\\.027231309701176574\ \(0\)\
\-\ but\\:\\ 0\\.026655638269592854\ \(0\)\
\-\ chicago\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ cfs\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ nagging\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ triggering\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ processing\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ psychological\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ aggregation\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ everywhere\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ geriatric\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ biology\\:\\ 0\\.026551446625895658\ \(0\)\
\-\ activity\\:\\ 0\\.026383618151033173\ \(0\)\
\-\ studies\\:\\ 0\\.026360997859040274\ \(0\)\
\-\ well\\:\\ 0\\.026100608019668188\ \(0\)\
\-\ gabapentin\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ tapers\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ photos\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ sloughing\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ iqbqal\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ assigned\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ girdle\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ waking\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ campylobacter\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ families\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ polymorphisms\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ paired\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ bernstein\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ jg\\:\\ 0\\.025848572940095495\ \(0\)\
\-\ care\\:\\ 0\\.025676964474669526\ \(0\)\
\-\ midpoint\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ spines\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ centimeters\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ weaker\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ michael\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ biological\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ inheritance\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ rheum\\:\\ 0\\.02527428332307607\ \(0\)\
\-\ new\\:\\ 0\\.02486112235025506\ \(0\)\
\-\ press\\:\\ 0\\.024788728370398003\ \(0\)\
\-\ modifications\\:\\ 0\\.024788728370398003\ \(0\)\
\-\ shigella\\:\\ 0\\.024788728370398003\ \(0\)\
\-\ aligned\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ pigmentation\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ alleviate\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ amitriptyline\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ resembling\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ twitching\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ excluding\\:\\ 0\\.024368121538825855\ \(0\)\
\-\ three\\:\\ 0\\.024123075196795143\ \(0\)\
\-\ central\\:\\ 0\\.023997703008315642\ \(0\)\
\-\ insertions\\:\\ 0\\.023997120020256477\ \(0\)\
\-\ costochondral\\:\\ 0\\.023997120020256477\ \(0\)\
\-\ junctions\\:\\ 0\\.023997120020256477\ \(0\)\
\-\ lifestyle\\:\\ 0\\.023997120020256477\ \(0\)\
\-\ jb\\:\\ 0\\.023997120020256477\ \(0\)\
\-\ joint\\:\\ 0\\.02368000151295072\ \(0\)\
\-\ elbows\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ monofilament\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ terminates\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ macules\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ mastitis\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ preliminary\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ me\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ ther\\:\\ 0\\.023665247853025685\ \(0\)\
\-\ out\\:\\ 0\\.02362126221045863\ \(0\)\
\-\ past\\:\\ 0\\.023391633343272433\ \(0\)\
\-\ acetaminophen\\:\\ 0\\.023365032960061954\ \(0\)\
\-\ cyclobenzaprine\\:\\ 0\\.023365032960061954\ \(0\)\
\-\ ever\\:\\ 0\\.023365032960061954\ \(0\)\
\-\ salmonella\\:\\ 0\\.023365032960061954\ \(0\)\
\-\ churchill\\:\\ 0\\.023365032960061954\ \(0\)\
\-\ between\\:\\ 0\\.023349494426614215\ \(0\)\
\-\ trapezius\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ brachioradialis\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ ama\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ ache\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ stabbing\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ regards\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ cd\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ ann\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ dis\\:\\ 0\\.02309095823600626\ \(0\)\
\-\ by\\:\\ 0\\.022890787051226866\ \(0\)\
\-\ inhibitors\\:\\ 0\\.0228388339302283\ \(0\)\
\-\ patches\\:\\ 0\\.0228388339302283\ \(0\)\
\-\ feel\\:\\ 0\\.0228388339302283\ \(0\)\
\-\ recall\\:\\ 0\\.0228388339302283\ \(0\)\
\-\ suboccipital\\:\\ 0\\.022605403283328197\ \(0\)\
\-\ instructed\\:\\ 0\\.022605403283328197\ \(0\)\
\-\ tenderness\\:\\ 0\\.02253634203281402\ \(0\)\
\-\ thorough\\:\\ 0\\.022388084550206095\ \(0\)\
\-\ ebv\\:\\ 0\\.022388084550206095\ \(0\)\
\-\ guide\\:\\ 0\\.022388084550206095\ \(0\)\
\-\ chapter\\:\\ 0\\.022388084550206095\ \(0\)\
\-\ eds\\:\\ 0\\.022388084550206095\ \(0\)\
\-\ doses\\:\\ 0\\.022184796451756045\ \(0\)\
\-\ recovering\\:\\ 0\\.022184796451756045\ \(0\)\
\-\ concluded\\:\\ 0\\.022184796451756045\ \(0\)\
\-\ explain\\:\\ 0\\.021993836636267777\ \(0\)\
\-\ evaluation\\:\\ 0\\.02191581022629737\ \(0\)\
\-\ loss\\:\\ 0\\.021893549621680827\ \(0\)\
\-\ dynamometer\\:\\ 0\\.02181379493318667\ \(0\)\
\-\ tried\\:\\ 0\\.02181379493318667\ \(0\)\
\-\ level\\:\\ 0\\.02170744458972462\ \(0\)\
\-\ when\\:\\ 0\\.02170744458972462\ \(0\)\
\-\ adequately\\:\\ 0\\.021643490091879828\ \(0\)\
\-\ jamar\\:\\ 0\\.021643490091879828\ \(0\)\
\-\ herniations\\:\\ 0\\.021643490091879828\ \(0\)\
\-\ correlated\\:\\ 0\\.021643490091879828\ \(0\)\
\-\ abnormal\\:\\ 0\\.021589888693381448\ \(0\)\
\-\ msiii\\:\\ 0\\.02148192276595588\ \(0\)\
\-\ met\\:\\ 0\\.02148192276595588\ \(0\)\
\-\ all\\:\\ 0\\.02139186553063723\ \(0\)\
\-\ epidermal\\:\\ 0\\.021328239980508607\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.021328239980508607\ \(0\)\
\-\ secondary\\:\\ 0\\.021300194226784863\ \(0\)\
\-\ quadrants\\:\\ 0\\.02118170787299215\ \(0\)\
\-\ discs\\:\\ 0\\.02118170787299215\ \(0\)\
\-\ months\\:\\ 0\\.02091767980332792\ \(0\)\
\-\ shallow\\:\\ 0\\.020907633148936455\ \(0\)\
\-\ nervous\\:\\ 0\\.020907633148936455\ \(0\)\
\-\ points\\:\\ 0\\.020907633148936455\ \(0\)\
\-\ if\\:\\ 0\\.02087972942017749\ \(0\)\
\-\ scapula\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ aspirin\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ disturbances\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ anxiety\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ 1990\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ measurement\\:\\ 0\\.020655508843158494\ \(0\)\
\-\ an\\:\\ 0\\.020612728793088845\ \(0\)\
\-\ one\\:\\ 0\\.0205750670222708\ \(0\)\
\-\ allergic\\:\\ 0\\.02053663163036708\ \(0\)\
\-\ multiplanar\\:\\ 0\\.02042207819625839\ \(0\)\
\-\ concomitant\\:\\ 0\\.02042207819625839\ \(0\)\
\-\ 6th\\:\\ 0\\.02042207819625839\ \(0\)\
\-\ march\\:\\ 0\\.02042207819625839\ \(0\)\
\-\ permanent\\:\\ 0\\.0203115450208649\ \(0\)\
\-\ ibuprofen\\:\\ 0\\.0203115450208649\ \(0\)\
\-\ accessed\\:\\ 0\\.0203115450208649\ \(0\)\
\-\ anterior\\:\\ 0\\.02006458206846179\ \(0\)\
\-\ both\\:\\ 0\\.02003969825249448\ \(0\)\
\-\ relation\\:\\ 0\\.02000147136468624\ \(0\)\
\-\ over\\:\\ 0\\.01998201542717484\ \(0\)\
\-\ hospitalization\\:\\ 0\\.019810511549197968\ \(0\)\
\-\ lyme\\:\\ 0\\.01971920451045822\ \(0\)\
\-\ unenhanced\\:\\ 0\\.019630469846116865\ \(0\)\
\-\ 2013\\:\\ 0\\.019630469846116865\ \(0\)\
\-\ post\\:\\ 0\\.019553943615043985\ \(0\)\
\-\ diet\\:\\ 0\\.019544166576937347\ \(0\)\
\-\ maintain\\:\\ 0\\.019544166576937347\ \(0\)\
\-\ furthermore\\:\\ 0\\.019544166576937347\ \(0\)\
\-\ constant\\:\\ 0\\.019378345540338904\ \(0\)\
\-\ shoulders\\:\\ 0\\.019378345540338904\ \(0\)\
\-\ seven\\:\\ 0\\.019378345540338904\ \(0\)\
\-\ conus\\:\\ 0\\.01929859767888607\ \(0\)\
\-\ closely\\:\\ 0\\.01929859767888607\ \(0\)\
\-\ supraspinatus\\:\\ 0\\.01922081910307148\ \(0\)\
\-\ impairment\\:\\ 0\\.019144914893438798\ \(0\)\
\-\ cold\\:\\ 0\\.019144914893438798\ \(0\)\
\-\ 2010\\:\\ 0\\.019144914893438798\ \(0\)\
\-\ maximum\\:\\ 0\\.019070796832011492\ \(0\)\
\-\ sequelae\\:\\ 0\\.019070796832011492\ \(0\)\
\-\ tobacco\\:\\ 0\\.019070796832011492\ \(0\)\
\-\ associated\\:\\ 0\\.01894098533068527\ \(0\)\
\-\ muscular\\:\\ 0\\.018927596160316695\ \(0\)\
\-\ receive\\:\\ 0\\.018927596160316695\ \(0\)\
\-\ caliber\\:\\ 0\\.018858365411391624\ \(0\)\
\-\ locations\\:\\ 0\\.018790623611809214\ \(0\)\
\-\ depression\\:\\ 0\\.018724308061866646\ \(0\)\
\-\ 84\\:\\ 0\\.018659359940760734\ \(0\)\
\-\ forearm\\:\\ 0\\.018659359940760734\ \(0\)\
\-\ toe\\:\\ 0\\.018595723993085903\ \(0\)\
\-\ index\\:\\ 0\\.018595723993085903\ \(0\)\
\-\ triceps\\:\\ 0\\.018472183756088688\ \(0\)\
\-\ tirone\\:\\ 0\\.018472183756088688\ \(0\)\
\-\ syndromes\\:\\ 0\\.018472183756088688\ \(0\)\
\-\ mri\\:\\ 0\\.018446371813362672\ \(0\)\
\-\ grip\\:\\ 0\\.018353306543297275\ \(0\)\
\-\ sleep\\:\\ 0\\.018353306543297275\ \(0\)\
\-\ charles\\:\\ 0\\.018295509100122172\ \(0\)\
\-\ vaseem\\:\\ 0\\.018295509100122172\ \(0\)\
\-\ take\\:\\ 0\\.01823875310918858\ \(0\)\
\-\ 61\\:\\ 0\\.01823875310918858\ \(0\)\
\-\ arthropathy\\:\\ 0\\.018183001701990432\ \(0\)\
\-\ deposition\\:\\ 0\\.01812821993379509\ \(0\)\
\-\ arms\\:\\ 0\\.01812821993379509\ \(0\)\
\-\ specifically\\:\\ 0\\.018074374652086736\ \(0\)\
\-\ according\\:\\ 0\\.018074374652086736\ \(0\)\
\-\ affecting\\:\\ 0\\.018074374652086736\ \(0\)\
\-\ biceps\\:\\ 0\\.01802143437606648\ \(0\)\
\-\ various\\:\\ 0\\.01796936918611263\ \(0\)\
\-\ 2000\\:\\ 0\\.01796936918611263\ \(0\)\
\-\ have\\:\\ 0\\.0179520206815355\ \(0\)\
\-\ 2006\\:\\ 0\\.017918150622229127\ \(0\)\
\-\ chiropractic\\:\\ 0\\.01781814627761643\ \(0\)\
\-\ noticed\\:\\ 0\\.01781814627761643\ \(0\)\
\-\ criteria\\:\\ 0\\.01781814627761643\ \(0\)\
\-\ mode\\:\\ 0\\.017769310070288518\ \(0\)\
\-\ randall\\:\\ 0\\.01772121948310275\ \(0\)\
\-\ loftus\\:\\ 0\\.01772121948310275\ \(0\)\
\-\ genetic\\:\\ 0\\.01772121948310275\ \(0\)\
\-\ 67\\:\\ 0\\.017673852090105843\ \(0\)\
\-\ little\\:\\ 0\\.017673852090105843\ \(0\)\
\-\ insertion\\:\\ 0\\.01762718646212816\ \(0\)\
\-\ death\\:\\ 0\\.01762718646212816\ \(0\)\
\-\ nsaids\\:\\ 0\\.01758120210857203\ \(0\)\
\-\ protocol\\:\\ 0\\.017535879423388415\ \(0\)\
\-\ achilles\\:\\ 0\\.017535879423388415\ \(0\)\
\-\ contributors\\:\\ 0\\.01749119963488542\ \(0\)\
\-\ dysfunction\\:\\ 0\\.01744714475904706\ \(0\)\
\-\ facet\\:\\ 0\\.01740369755607173\ \(0\)\
\-\ requires\\:\\ 0\\.01740369755607173\ \(0\)\
\-\ krishnan\\:\\ 0\\.01736084148986754\ \(0\)\
\-\ kartha\\:\\ 0\\.01736084148986754\ \(0\)\
\-\ systems\\:\\ 0\\.01736084148986754\ \(0\)\
\-\ patellar\\:\\ 0\\.017318560690266313\ \(0\)\
\-\ 68\\:\\ 0\\.017276839917740216\ \(0\)\
\-\ outer\\:\\ 0\\.017276839917740216\ \(0\)\
\-\ we\\:\\ 0\\.017276839917740216\ \(0\)\
\-\ joanna\\:\\ 0\\.017235664530424685\ \(0\)\
\-\ garvey\\:\\ 0\\.017235664530424685\ \(0\)\
\-\ serghany\\:\\ 0\\.017235664530424685\ \(0\)\
\-\ geoffrey\\:\\ 0\\.017195020453269098\ \(0\)\
\-\ gerow\\:\\ 0\\.017195020453269098\ \(0\)\
\-\ developing\\:\\ 0\\.017195020453269098\ \(0\)\
\-\ 2002\\:\\ 0\\.017195020453269098\ \(0\)\
\-\ continues\\:\\ 0\\.017154894149152528\ \(0\)\
\-\ remains\\:\\ 0\\.017115272591816263\ \(0\)\
\-\ 62\\:\\ 0\\.017115272591816263\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.01703749401600167\ \(0\)\
\-\ each\\:\\ 0\\.01703749401600167\ \(0\)\
\-\ rom\\:\\ 0\\.016999313278516295\ \(0\)\
\-\ joseph\\:\\ 0\\.016999313278516295\ \(0\)\
\-\ population\\:\\ 0\\.016999313278516295\ \(0\)\
\-\ sensory\\:\\ 0\\.016924312776327995\ \(0\)\
\-\ exercise\\:\\ 0\\.016924312776327995\ \(0\)\
\-\ instability\\:\\ 0\\.016924312776327995\ \(0\)\
\-\ 64\\:\\ 0\\.016887471744941682\ \(0\)\
\-\ nerves\\:\\ 0\\.0167794655430297\ \(0\)\
\-\ 5th\\:\\ 0\\.01670946550059103\ \(0\)\
\-\ discomfort\\:\\ 0\\.016607298524739408\ \(0\)\
\-\ alcohol\\:\\ 0\\.016607298524739408\ \(0\)\
\-\ least\\:\\ 0\\.016607298524739408\ \(0\)\
\-\ 85\\:\\ 0\\.016573966231940046\ \(0\)\
\-\ dorsal\\:\\ 0\\.016573966231940046\ \(0\)\
\-\ overall\\:\\ 0\\.016508341519213925\ \(0\)\
\-\ characterized\\:\\ 0\\.016508341519213925\ \(0\)\
\-\ mva\\:\\ 0\\.016508341519213925\ \(0\)\
\-\ has\\:\\ 0\\.016414533746417513\ \(0\)\
\-\ conditions\\:\\ 0\\.016412398906016097\ \(0\)\
\-\ drug\\:\\ 0\\.01635002315930857\ \(0\)\
\-\ epidural\\:\\ 0\\.016319292454330663\ \(0\)\
\-\ erythema\\:\\ 0\\.016258716120568825\ \(0\)\
\-\ complaining\\:\\ 0\\.016258716120568825\ \(0\)\
\-\ baby\\:\\ 0\\.016199282804972757\ \(0\)\
\-\ suggesting\\:\\ 0\\.016199282804972757\ \(0\)\
\-\ testing\\:\\ 0\\.016140950169837187\ \(0\)\
\-\ rotation\\:\\ 0\\.015999676614920626\ \(0\)\
\-\ improved\\:\\ 0\\.015944894846725285\ \(0\)\
\-\ still\\:\\ 0\\.015917857150449508\ \(0\)\
\-\ our\\:\\ 0\\.015917857150449508\ \(0\)\
\-\ border\\:\\ 0\\.01589104956501693\ \(0\)\
\-\ fevers\\:\\ 0\\.015864468206630504\ \(0\)\
\-\ medicine\\:\\ 0\\.015838109288996673\ \(0\)\
\-\ current\\:\\ 0\\.015734825535159317\ \(0\)\
\-\ reflexes\\:\\ 0\\.015709525220215927\ \(0\)\
\-\ tendon\\:\\ 0\\.0156844265035494\ \(0\)\
\-\ having\\:\\ 0\\.015490527003036037\ \(0\)\
\-\ sensation\\:\\ 0\\.015397877021502224\ \(0\)\
\-\ disorder\\:\\ 0\\.015198871550871336\ \(0\)\
\-\ gi\\:\\ 0\\.015093514830670405\ \(0\)\
\-\ medications\\:\\ 0\\.01507285985648898\ \(0\)\
\-\ per\\:\\ 0\\.014912322068824157\ \(0\)\
\-\ their\\:\\ 0\\.014912322068824157\ \(0\)\
\-\ development\\:\\ 0\\.014854168928931863\ \(0\)\
\-\ point\\:\\ 0\\.014854168928931863\ \(0\)\
\-\ review\\:\\ 0\\.014797069982771655\ \(0\)\
\-\ using\\:\\ 0\\.014778264719299184\ \(0\)\
\-\ neurological\\:\\ 0\\.01475957106042133\ \(0\)\
\-\ provided\\:\\ 0\\.014740987689258186\ \(0\)\
\-\ cranial\\:\\ 0\\.014685886477598676\ \(0\)\
\-\ 17\\:\\ 0\\.014667731543905693\ \(0\)\
\-\ test\\:\\ 0\\.014613886262197338\ \(0\)\
\-\ last\\:\\ 0\\.014613886262197338\ \(0\)\
\-\ down\\:\\ 0\\.014596140455959894\ \(0\)\
\-\ described\\:\\ 0\\.014578494066525394\ \(0\)\
\-\ function\\:\\ 0\\.0145434951256092\ \(0\)\
\-\ characteristic\\:\\ 0\\.014526140413521222\ \(0\)\
\-\ diameter\\:\\ 0\\.014440772796294455\ \(0\)\
\-\ 45\\:\\ 0\\.014407263200729811\ \(0\)\
\-\ recurrent\\:\\ 0\\.014407263200729811\ \(0\)\
\-\ ed\\:\\ 0\\.014374106344298854\ \(0\)\
\-\ administration\\:\\ 0\\.01430882168039912\ \(0\)\
\-\ there\\:\\ 0\\.014298836840712245\ \(0\)\
\-\ done\\:\\ 0\\.01429270976662112\ \(0\)\
\-\ motor\\:\\ 0\\.01429270976662112\ \(0\)\
\-\ foot\\:\\ 0\\.014197731547657215\ \(0\)\
\-\ limits\\:\\ 0\\.014197731547657215\ \(0\)\
\-\ not\\:\\ 0\\.014186691829690838\ \(0\)\
\-\ 22\\:\\ 0\\.014151295243131695\ \(0\)\
\-\ prominent\\:\\ 0\\.014151295243131695\ \(0\)\
\-\ upon\\:\\ 0\\.014135967367260853\ \(0\)\
\-\ range\\:\\ 0\\.013943209166182333\ \(0\)\
\-\ motion\\:\\ 0\\.013928858925982557\ \(0\)\
\-\ made\\:\\ 0\\.013858072300376917\ \(0\)\
\-\ persistent\\:\\ 0\\.01384410388601866\ \(0\)\
\-\ symptomatic\\:\\ 0\\.013816351527850816\ \(0\)\
\-\ history\\:\\ 0\\.01372964577218131\ \(0\)\
\-\ worsening\\:\\ 0\\.013721099751869434\ \(0\)\
\-\ system\\:\\ 0\\.013707724477947122\ \(0\)\
\-\ similar\\:\\ 0\\.01369440575926313\ \(0\)\
\-\ diagnostic\\:\\ 0\\.01369440575926313\ \(0\)\
\-\ pressure\\:\\ 0\\.013681143119560698\ \(0\)\
\-\ rate\\:\\ 0\\.013615654850588287\ \(0\)\
\-\ unknown\\:\\ 0\\.013615654850588287\ \(0\)\
\-\ specific\\:\\ 0\\.013615654850588287\ \(0\)\
\-\ second\\:\\ 0\\.013451496103476818\ \(0\)\
\-\ about\\:\\ 0\\.013451496103476818\ \(0\)\
\-\ 60\\:\\ 0\\.013439215884118364\ \(0\)\
\-\ 14\\:\\ 0\\.013414798147300077\ \(0\)\
\-\ headaches\\:\\ 0\\.013402659896148906\ \(0\)\
\-\ skin\\:\\ 0\\.013366523297791533\ \(0\)\
\-\ cord\\:\\ 0\\.013318977153140305\ \(0\)\
\-\ referred\\:\\ 0\\.013295470534525662\ \(0\)\
\-\ http\\:\\ 0\\.013283782683357493\ \(0\)\
\-\ confirmed\\:\\ 0\\.013248977110701634\ \(0\)\
\-\ greater\\:\\ 0\\.01323746019741139\ \(0\)\
\-\ ago\\:\\ 0\\.013146810134850011\ \(0\)\
\-\ abnormality\\:\\ 0\\.013069576472500274\ \(0\)\
\-\ intact\\:\\ 0\\.013004850792146954\ \(0\)\
\-\ above\\:\\ 0\\.012962427628654457\ \(0\)\
\-\ they\\:\\ 0\\.012838482237334763\ \(0\)\
\-\ risk\\:\\ 0\\.012838482237334763\ \(0\)\
\-\ otherwise\\:\\ 0\\.012808243231250432\ \(0\)\
\-\ would\\:\\ 0\\.01271922992811233\ \(0\)\
\-\ involving\\:\\ 0\\.012585578935070634\ \(0\)\
\-\ does\\:\\ 0\\.012421675774945637\ \(0\)\
\-\ side\\:\\ 0\\.012412815368890088\ \(0\)\
\-\ given\\:\\ 0\\.012360170038539392\ \(0\)\
\-\ cause\\:\\ 0\\.012240648350599794\ \(0\)\
\-\ fever\\:\\ 0\\.012182546292340488\ \(0\)\
\-\ possible\\:\\ 0\\.012174332800657226\ \(0\)\
\-\ recent\\:\\ 0\\.012166140670484901\ \(0\)\
\-\ first\\:\\ 0\\.012125496593329316\ \(0\)\
\-\ palpation\\:\\ 0\\.01211743033469393\ \(0\)\
\-\ week\\:\\ 0\\.012085370289212746\ \(0\)\
\-\ space\\:\\ 0\\.0119602968945918\ \(0\)\
\-\ radiation\\:\\ 0\\.0119071011648367\ \(0\)\
\-\ positive\\:\\ 0\\.01184000075647536\ \(0\)\
\-\ medial\\:\\ 0\\.011695816671636217\ \(0\)\
\-\ aspect\\:\\ 0\\.011591851053465479\ \(0\)\
\-\ medical\\:\\ 0\\.011419393924903208\ \(0\)\
\-\ severe\\:\\ 0\\.011374532320343375\ \(0\)\
\-\ fat\\:\\ 0\\.011177215545531433\ \(0\)\
\-\ negative\\:\\ 0\\.01112387682889642\ \(0\)\
\-\ his\\:\\ 0\\.010897169497837636\ \(0\)\
\-\ following\\:\\ 0\\.010779102541584649\ \(0\)\
\-\ likely\\:\\ 0\\.010737243157767817\ \(0\)\
\-\ through\\:\\ 0\\.010695932765318616\ \(0\)\
\-\ include\\:\\ 0\\.010690806853242297\ \(0\)\
\-\ however\\:\\ 0\\.010634965592175966\ \(0\)\
\-\ trauma\\:\\ 0\\.010435138719291056\ \(0\)\
\-\ significant\\:\\ 0\\.010374337515118572\ \(0\)\
\-\ due\\:\\ 0\\.010328353161562442\ \(0\)\
\-\ lesions\\:\\ 0\\.01031923630345906\ \(0\)\
\-\ high\\:\\ 0\\.01021184389238578\ \(0\)\
\-\ mild\\:\\ 0\\.010185558296654577\ \(0\)\
\-\ than\\:\\ 0\\.010185558296654577\ \(0\)\
\-\ who\\:\\ 0\\.010163819961404596\ \(0\)\
\-\ these\\:\\ 0\\.01014653666824399\ \(0\)\
\-\ acute\\:\\ 0\\.009720010539630739\ \(0\)\
\-\ follow\\:\\ 0\\.009686321744960614\ \(0\)\
\-\ surgery\\:\\ 0\\.00966036620559313\ \(0\)\
\-\ noted\\:\\ 0\\.009526616596020113\ \(0\)\
\-\ imaging\\:\\ 0\\.009442801302155105\ \(0\)\
\-\ woman\\:\\ 0\\.009357802289356376\ \(0\)\
\-\ most\\:\\ 0\\.009351100430922252\ \(0\)\
\-\ other\\:\\ 0\\.00933107998888937\ \(0\)\
\-\ present\\:\\ 0\\.009219973390058391\ \(0\)\
\-\ it\\:\\ 0\\.009197577047933241\ \(0\)\
\-\ exam\\:\\ 0\\.00904510902234513\ \(0\)\
\-\ may\\:\\ 0\\.00904207300063947\ \(0\)\
\-\ case\\:\\ 0\\.009026936631888345\ \(0\)\
\-\ up\\:\\ 0\\.008888101222827597\ \(0\)\
\-\ findings\\:\\ 0\\.008867937362538457\ \(0\)\
\-\ after\\:\\ 0\\.008716579862329902\ \(0\)\
\-\ treatment\\:\\ 0\\.008559120173079042\ \(0\)\
\-\ seen\\:\\ 0\\.008459197179523979\ \(0\)\
\-\ within\\:\\ 0\\.008275514814594154\ \(0\)\
\-\ which\\:\\ 0\\.008170236353839419\ \(0\)\
\-\ disease\\:\\ 0\\.007542335449189286\ \(0\)\
\-\ this\\:\\ 0\\.006174134408042696\ \(0\)\
\-\ year\\:\\ 0\\.005537389249200523\ \(0\)\
